Can histoplasmosis cause dilated cardiomyopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Histoplasmosis and Dilated Cardiomyopathy

Histoplasmosis is not recognized as a direct cause of dilated cardiomyopathy in major clinical guidelines. While histoplasmosis can cause various clinical manifestations, including pulmonary and disseminated disease, there is no established causal relationship between histoplasmosis and the development of dilated cardiomyopathy in the current medical literature.

Known Causes of Dilated Cardiomyopathy

Dilated cardiomyopathy (DCM) can result from various etiologies:

  • Genetic factors: Account for 20-35% of DCM cases 1
  • Infectious causes: Several pathogens are recognized as potential causes of DCM:
    • HIV infection can lead to cardiomyopathy, with reduced left ventricular ejection fraction correlating with decreased survival 2
    • Chagas disease (caused by Trypanosoma cruzi) is a well-established cause of DCM, particularly in Central and South America 2
    • Viral infections (particularly enteroviruses, cytomegalovirus, adenoviruses, parvovirus B19, human herpesvirus, and Epstein-Barr virus) 3
    • Bacterial infections such as Borrelia burgdorferi and Chlamydia pneumoniae 3
  • Toxic exposures: Including alcohol, cocaine, and chemotherapeutic drugs 1
  • Autoimmune diseases: Such as systemic lupus erythematosus 2
  • Endocrinopathies: Including thyroid disease 2

Histoplasmosis Clinical Manifestations

Histoplasmosis presents with various clinical manifestations:

  • Acute pulmonary histoplasmosis: Characterized by fever, chills, headache, myalgia, cough, and chest pain 4
  • Disseminated histoplasmosis: More common in immunocompromised patients, presenting with fever, fatigue, weight loss, hepatosplenomegaly, and lymphadenopathy 4
  • Complications of pulmonary histoplasmosis: Include mediastinal lymphadenitis, mediastinal granuloma, chronic cavitary disease, fibrosing mediastinitis, and broncholithiasis 2

Evidence Regarding Histoplasmosis and Cardiac Involvement

The available guidelines and research do not establish histoplasmosis as a cause of dilated cardiomyopathy:

  • The Infectious Diseases Society of America guidelines on histoplasmosis management do not mention dilated cardiomyopathy as a complication or manifestation of histoplasmosis 2
  • The American Heart Association's scientific statement on specific dilated cardiomyopathies does not list histoplasmosis among the infectious causes of DCM 2
  • While one case report describes a heart transplant recipient who developed disseminated histoplasmosis, the patient had pre-existing dilated cardiomyopathy before the histoplasmosis infection 5

Clinical Implications

For patients with dilated cardiomyopathy:

  • A comprehensive etiologic workup should focus on established causes such as genetic factors, viral infections (particularly those mentioned above), Chagas disease in endemic areas, toxic exposures, and autoimmune conditions 6
  • If histoplasmosis is diagnosed in a patient with DCM, it should be considered a coincidental finding rather than the cause of the cardiomyopathy, unless other evidence suggests otherwise 2, 4
  • Treatment should be directed at both the underlying cause of DCM (when identified) and standard heart failure management according to guidelines 2

Conclusion

Based on current medical evidence and guidelines, histoplasmosis is not recognized as a direct cause of dilated cardiomyopathy. Clinicians evaluating patients with DCM should focus on established etiologies while managing histoplasmosis separately if present.

References

Research

Histological and immunohistochemical changes of the myocardium in dilated cardiomyopathy.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clinical Manifestations of Histoplasmosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.